vs

Side-by-side financial comparison of AVIAT NETWORKS, INC. (AVNW) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

AVIAT NETWORKS, INC. is the larger business by last-quarter revenue ($111.5M vs $75.5M, roughly 1.5× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -5.7%). AVIAT NETWORKS, INC. produced more free cash flow last quarter ($22.5M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 0.3%).

Aviat Networks, Inc. is a global provider of microwave transport and backhaul solutions, providing public and private operators with communications infrastructure to serve telecommunications operators and enterprise customers.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

AVNW vs PBYI — Head-to-Head

Bigger by revenue
AVNW
AVNW
1.5× larger
AVNW
$111.5M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+33.4% gap
PBYI
27.7%
-5.7%
AVNW
More free cash flow
AVNW
AVNW
$8.1M more FCF
AVNW
$22.5M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
0.3%
AVNW

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AVNW
AVNW
PBYI
PBYI
Revenue
$111.5M
$75.5M
Net Profit
$5.7M
Gross Margin
32.4%
69.3%
Operating Margin
6.5%
22.7%
Net Margin
5.1%
Revenue YoY
-5.7%
27.7%
Net Profit YoY
27.2%
EPS (diluted)
$0.44
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVNW
AVNW
PBYI
PBYI
Q4 25
$111.5M
$75.5M
Q3 25
$107.3M
$54.5M
Q2 25
$115.3M
$52.4M
Q1 25
$112.6M
$46.0M
Q4 24
$118.2M
$59.1M
Q3 24
$88.4M
$80.5M
Q2 24
$116.7M
$47.1M
Q1 24
$110.8M
$43.8M
Net Profit
AVNW
AVNW
PBYI
PBYI
Q4 25
$5.7M
Q3 25
$162.0K
$8.8M
Q2 25
$5.2M
$5.9M
Q1 25
$3.5M
$3.0M
Q4 24
$4.5M
Q3 24
$-11.9M
$20.3M
Q2 24
$1.5M
$-4.5M
Q1 24
$3.9M
$-4.8M
Gross Margin
AVNW
AVNW
PBYI
PBYI
Q4 25
32.4%
69.3%
Q3 25
33.2%
77.7%
Q2 25
34.2%
76.5%
Q1 25
34.9%
77.1%
Q4 24
34.6%
76.4%
Q3 24
22.4%
63.9%
Q2 24
35.3%
77.4%
Q1 24
32.5%
75.5%
Operating Margin
AVNW
AVNW
PBYI
PBYI
Q4 25
6.5%
22.7%
Q3 25
4.8%
17.6%
Q2 25
7.7%
12.7%
Q1 25
8.3%
8.7%
Q4 24
6.7%
22.6%
Q3 24
-17.6%
27.4%
Q2 24
4.7%
-4.6%
Q1 24
5.1%
-5.3%
Net Margin
AVNW
AVNW
PBYI
PBYI
Q4 25
5.1%
Q3 25
0.2%
16.2%
Q2 25
4.5%
11.2%
Q1 25
3.1%
6.5%
Q4 24
3.8%
Q3 24
-13.4%
25.2%
Q2 24
1.3%
-9.6%
Q1 24
3.5%
-11.0%
EPS (diluted)
AVNW
AVNW
PBYI
PBYI
Q4 25
$0.44
$0.26
Q3 25
$0.01
$0.17
Q2 25
$0.42
$0.12
Q1 25
$0.27
$0.06
Q4 24
$0.35
$0.40
Q3 24
$-0.94
$0.41
Q2 24
$0.11
$-0.09
Q1 24
$0.30
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVNW
AVNW
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$86.5M
$97.5M
Total DebtLower is stronger
$105.4M
$22.7M
Stockholders' EquityBook value
$271.6M
$130.3M
Total Assets
$659.4M
$216.3M
Debt / EquityLower = less leverage
0.39×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVNW
AVNW
PBYI
PBYI
Q4 25
$86.5M
$97.5M
Q3 25
$64.8M
$94.4M
Q2 25
$59.7M
$96.0M
Q1 25
$49.4M
$93.2M
Q4 24
$52.6M
$101.0M
Q3 24
$51.0M
$96.7M
Q2 24
$64.6M
$96.8M
Q1 24
$59.2M
$107.2M
Total Debt
AVNW
AVNW
PBYI
PBYI
Q4 25
$105.4M
$22.7M
Q3 25
$106.5M
$34.0M
Q2 25
$87.6M
$45.3M
Q1 25
$73.9M
$56.7M
Q4 24
$74.9M
$68.0M
Q3 24
$83.4M
$79.3M
Q2 24
$48.4M
$90.7M
Q1 24
$48.9M
$102.0M
Stockholders' Equity
AVNW
AVNW
PBYI
PBYI
Q4 25
$271.6M
$130.3M
Q3 25
$263.6M
$115.3M
Q2 25
$263.2M
$104.7M
Q1 25
$256.1M
$97.1M
Q4 24
$249.6M
$92.1M
Q3 24
$247.1M
$71.1M
Q2 24
$255.9M
$48.5M
Q1 24
$256.0M
$51.0M
Total Assets
AVNW
AVNW
PBYI
PBYI
Q4 25
$659.4M
$216.3M
Q3 25
$643.3M
$202.9M
Q2 25
$633.3M
$194.9M
Q1 25
$628.3M
$196.2M
Q4 24
$594.1M
$213.3M
Q3 24
$590.9M
$220.7M
Q2 24
$535.2M
$205.0M
Q1 24
$490.3M
$214.1M
Debt / Equity
AVNW
AVNW
PBYI
PBYI
Q4 25
0.39×
0.17×
Q3 25
0.40×
0.30×
Q2 25
0.33×
0.43×
Q1 25
0.29×
0.58×
Q4 24
0.30×
0.74×
Q3 24
0.34×
1.12×
Q2 24
0.19×
1.87×
Q1 24
0.19×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVNW
AVNW
PBYI
PBYI
Operating Cash FlowLast quarter
$23.9M
$14.4M
Free Cash FlowOCF − Capex
$22.5M
$14.4M
FCF MarginFCF / Revenue
20.2%
19.1%
Capex IntensityCapex / Revenue
1.3%
0.0%
Cash ConversionOCF / Net Profit
4.18×
TTM Free Cash FlowTrailing 4 quarters
$16.1M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVNW
AVNW
PBYI
PBYI
Q4 25
$23.9M
$14.4M
Q3 25
$-11.7M
$9.7M
Q2 25
$10.5M
$14.1M
Q1 25
$1.6M
$3.6M
Q4 24
$20.8M
$15.6M
Q3 24
$-27.2M
$11.0M
Q2 24
$8.3M
$1.0M
Q1 24
$15.3M
$11.2M
Free Cash Flow
AVNW
AVNW
PBYI
PBYI
Q4 25
$22.5M
$14.4M
Q3 25
$-13.5M
$9.7M
Q2 25
$8.2M
$14.1M
Q1 25
$-1.2M
$3.6M
Q4 24
$18.3M
$15.6M
Q3 24
$-32.6M
$11.0M
Q2 24
$7.5M
$1.0M
Q1 24
$14.8M
FCF Margin
AVNW
AVNW
PBYI
PBYI
Q4 25
20.2%
19.1%
Q3 25
-12.6%
17.7%
Q2 25
7.1%
26.8%
Q1 25
-1.0%
7.7%
Q4 24
15.5%
26.4%
Q3 24
-36.8%
13.7%
Q2 24
6.4%
2.1%
Q1 24
13.4%
Capex Intensity
AVNW
AVNW
PBYI
PBYI
Q4 25
1.3%
0.0%
Q3 25
1.6%
0.0%
Q2 25
2.0%
0.0%
Q1 25
2.5%
0.1%
Q4 24
2.1%
0.0%
Q3 24
6.1%
0.0%
Q2 24
0.7%
0.0%
Q1 24
0.4%
0.0%
Cash Conversion
AVNW
AVNW
PBYI
PBYI
Q4 25
4.18×
Q3 25
-72.48×
1.10×
Q2 25
2.02×
2.41×
Q1 25
0.46×
1.21×
Q4 24
4.62×
Q3 24
0.54×
Q2 24
5.37×
Q1 24
3.96×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVNW
AVNW

Products$81.2M73%
Services$30.3M27%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons